Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (10): 7-13    DOI:
    
Effect of Low Expression of CENP-E on Breast Cancer Cell Line MCF-7
ZHAN Xiao-qin, HU Min, SONG Pei-pei, ZHANG Fan, LIU Chen, SHI Qiong, WENG Ya-guang
Key Laboratory for Clinical Laboratory Diagnostics of Education Ministry, College of Laboratory Medical, Chongqing Medical University, Chongqing 400016, China
Download: HTML   PDF(1378KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective To explore the role of mitotic protein CENP-E in cancer.Methods Plasmid vector containing CENP-E special short hair RNA(shRNA)was transfected into human breast cancer MCF-7 cells.Nest PCR and Western blot was used to detect CENP-E mRNA and protein level;the proliferation of cells with down-regulated CENP-E were analyzed by MTT assay;the apoptosis of cells were detected by flow cytometry(FCM);the migration and invasion ability of cells were evaluated by transwell assay;indirect immunofluorescence was used to detect CENP-E protein and cell mitosis.Results Compared with the control group,the CENP-E mRNA and protein level in MCF-7 cells transfected shRNA-CENP-E were decreased; the cell growth were inhibited in shRNA-CENP-E group(P<0.05);the results of FCM showed that the cell apoptosis ratio were obviously increased after down-regulated CENP-E;indirect immunofluorescence indicated CENP-E protein was reduced after transfected with shRNA-CENP-E,and the nucleus showed abnormal caryogram;but the cell ability of migration and invasion in shRNA-CENP-E group were increased(P<0.05). Conclusion: Down-regulated part of CENP-E gene expression in breast cancer MCF-7 cells can inhibit cell proliferation,induce cell apoptosis,meanwhile enhance the cell ability of migration and invasion.

Key wordsAneuploidy      Mitotic checkpoint      CENP-E      Tumor     
Received: 19 July 2012      Published: 25 October 2012
ZTFLH:  Q751  
Cite this article:

ZHAN Xiao-qin, HU Min, SONG Pei-pei, ZHANG Fan, LIU Chen, SHI Qiong, WENG Ya-guang. Effect of Low Expression of CENP-E on Breast Cancer Cell Line MCF-7. China Biotechnology, 2012, 32(10): 7-13.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I10/7

[1] Weaver B A,Silk A D,Montagna C,et al.Aneuploidy acts both oncogenically and as a tumor suppressor.Cancer Cell, 2007,11: 25-36.
[2] Kops G J,Weaver B A,Cleveland D W.On the road to cancer: aneuploidy and the mitotic checkpoint.Nature,2005,5:773-785.
[3] Huszar D, Theoclitou M E, Skolnik J,et al. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev,2009,28:197-208.
[4] Janssen A,Medema R H.Mitosis as an anti-cancer target.Oncogene,2011, 30:2799-2809.
[5] Weaver B A, Cleveland D W.Does aneuploidy cause cancer.Current Opinion in Cell Biology 2006, 18:658-667.
[6] Janssen A,Kops G J,Medema R H.Targeting the mitotic checkpoint to kill tumor cells.Horm Canc,2011, 2:113-116.
[7] Yao X B,Abrieu A,Zheng Y,et al.CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint.Nature Cell Biology,2000, 2:484-491.
[8] Tanudji M, Shoemaker J, Lawrence L I,et al.Gene silencing of CENP-E by small Interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay.Molecular Biology of the Cell,2004, 15:3771-3781.
[9] Weaver B A, Bonday A Q,Putkey F R,et al.Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss.The Journal of Cell Biology, 2003,162(4): 551-563.
[10] Wood K W,Chua P, Sutton D,et al.Centromere-associated protein E: A motor that puts the brakes on the mitotic checkpoint.Clin Cancer Res,2008,14(23): 7588-7592.
[11] 刘子杰,翁亚光,李素彦等.用FRET方法研究与Mps1蛋白有相互作用的CENP-E蛋白结构域. 中国生物工程杂志,2009,29(4):28-34. Liu Z J, Weng Y G,Li S Y,et al. Study on the interaction between Mps1 and the structural domains of CENP-E protein by FRET. China Biotechnology, 2009,29(4):28-34.
[12] Mao Y,Abrieu A,Cleveland D W.Activating and silencing the mitotic checkpoint through CENP-E-dependent activation/inactivation of BubR1.Cell,2003,114(1): 87-98.
[13] 闫琛,凌康,翁亚光.CENP-E变异体在不同肿瘤细胞株及癌组织中的差异表达.中国生物制品学杂志.2010,23(7):678-682. Yan C,Ling K,Weng Y G.The expression difference and function of two CENP-E mRNA forms in different tumor tissues.Chin J Biologicals, 2010,23(7):678-682.
[14] Janssen A,Kops G J,Medema R H.Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. PNAS,2009,106(45): 19108-19113.
[15] Kops G J,Foltz D R,Cleveland D W.Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.PNAS, 2004, 101(23):8699-8704.
[1] ZHAO Meng-ze,LI Feng-zhi,WANG Peng-yin,LI Jian,XU Han-mei. Research Progress of Dual-target Blocking Therapy of PD-L1 and VEGF[J]. China Biotechnology, 2021, 41(9): 71-77.
[2] LV Hui-zhong,ZHAO Chen-chen,ZHU Lian,XU Na. Progress of Using Exosome for Drug Targeted Delivery in Tumor Therapy[J]. China Biotechnology, 2021, 41(5): 79-86.
[3] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[4] DENG Rui,ZENG Jia-li,LU Xue-mei. Screening and Structure-activity Relationship Analysis of Anti-tumor Derived Peptides Based on Musca domestica cecropin[J]. China Biotechnology, 2021, 41(11): 14-22.
[5] LIN Shi-xin,LIU Dong-chen,LEI Yun,XIONG Sheng,XIE Qiu-ling. Screening, Expression and Specificity Detection of Anti-TNF-α Nanobody[J]. China Biotechnology, 2020, 40(7): 15-21.
[6] YANG Wei,SONG Fang-xiang,WANG Shuai,ZHANG Li,WANG Hong-xia,LI Yan. Preparation and Application of Janus Nanoparticles in Drug Delivery System[J]. China Biotechnology, 2020, 40(7): 70-81.
[7] ZHANG Bao-hui,XIONG Hua-long,ZHANG Tian-ying,YUAN Quan. Research Progress on Vesicular Stomatitis Virus-based Oncolytic Virotherapy[J]. China Biotechnology, 2020, 40(6): 53-62.
[8] TONG Mei,CHENG Yong-qing,LIU Jin-yi,XU Chen. Construction of a Strain for Promoting Production of Small Molecule Antibodies in Periplasmic Space of Escherichia coli[J]. China Biotechnology, 2020, 40(5): 48-56.
[9] DAI Qi-nan,ZHANG Jing-hong. Advances in Molecular Mechanisms Related to Tumor Multi-drug Resistance, Autophagy, DNA Repair and Tumor Stem Cells[J]. China Biotechnology, 2020, 40(4): 69-77.
[10] QIAN Ying,QIAN Chen,BAI Xiao-qing,WANG Jing-jing. Application of Adjuvant in Cancer Immunotherapy[J]. China Biotechnology, 2020, 40(3): 96-103.
[11] XIAO Xue-jun,TANG Qi,XINHUA Nabi. CAR-T Therapy Targeting Tumor Microenvironment[J]. China Biotechnology, 2020, 40(12): 67-74.
[12] HE Xun,ZHANG Peng,ZHANG Jun-xiang. Progress in the Construction and Application of Organoids[J]. China Biotechnology, 2020, 40(12): 82-87.
[13] ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α[J]. China Biotechnology, 2019, 39(9): 62-67.
[14] LIU Yan,DAI Peng,ZHU Yun-feng. Research Progress of Exosome as Tumor Marker[J]. China Biotechnology, 2019, 39(8): 74-79.
[15] Hai-yin LV,Teng-fei WANG,Ren-jun PEI. Progress in Aptamer Based Tumor Immunotherapy[J]. China Biotechnology, 2019, 39(6): 55-61.